Background: Observational studies have explored the safety of magnetic resonance (MR) scanning of patients with cardiac implantable electronic devices (CIEDs) that are not Food and Drug Administration approved for MR scanning ("nonconditional"). However, concern has been raised that MR scanning that includes the thoracic region may pose a higher risk. This study examines the safety of MR scanning of thoracic versus nonthoracic regions of patients with CIEDs.
INTRODUCTION
It is estimated that among patients with a cardiac implantable electronic device (CIED), up to 75% will have an indication for magnetic resonance (MR) scanning to aid in the diagnosis and management of various complex medical issues in their lifetime. 1 Therefore, in recent years to address this need, device manufacturers have brought to the market CIEDs that are Food and Drug Administration (FDA) approved for MR imaging under specific conditions. However, the overwhelming majority of CIEDs in current use do not have such FDA labeling and are considered as "MR nonconditional." There are several concerns for scanning a patient with an MR nonconditional CIED, including potential inappropriate sensing and pacing, atrial or ventricular arrhythmias, lead heating, myocardial injury, and electrical resets to CIED programming. Thus, a recent expert consensus statement on the management of patients with both MR conditional and nonconditional CIEDs has addressed the management of these patients. 2 While for patients with MR conditional CIEDs there is an extensive body of evidence to support safety that includes computer modeling of multiple configurations of device components 3, 4 as well as multicenter randomized controlled trials [5] [6] [7] [8] and multicenter prospective cohort studies, [9] [10] [11] [12] [13] the body of evidence for patients with MR nonconditional CIEDs consists only of registry 14 and several large single-center observational cohorts. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Of particular interest is whether MR scanning of the thoracic region, including the heart, might pose a higher risk due to proximity of the generated magnetic gradient field and radiofrequency energy to the CIED system, as suggested from in vitro data. 26 The largest published registry, MagnaSafe, 14 examined the outcomes of 1,500 patients with MR nonconditional CIEDs, but specifically excluded MR of thoracic regions except for the cervical spine. Published data on thoracic MR scanning in CIED patients is less robust, the largest being from the Johns Hopkins cohort that included 257 patients 21, 25 and a recently published Oregon Health and Science University cohort that included 117 patients with thoracic scanning. 23 Therefore, a gap remains in the literature, and the purpose of this study was to investigate the relative safety of thoracic versus nonthoracic MR scanning in CIED patients.
METHODS

Patient population
Patients with a CIED, including pacemaker, implantable cardioverter defibrillator (ICD), and cardiac resynchronization therapy (CRT) over the age of 18 were prospectively enrolled from the University of Arizona (Banner University Medical Center). All subjects provided informed written consent to undergo MR imaging and to participate in this study with approval from the hospital institutional human subjects review board. This manuscript reports a retrospective analysis of the patients imaged from December 2013 to July 2016.
Institutional protocol
An institutional protocol was followed for the evaluation and management of CIED patients undergoing MR imaging. 27 Patients underwent an initial complete CIED evaluation that included documentation of specific hardware, device programming, and determination of pacing dependency. The protocol excluded patients who were pacing dependent without a hemodynamically tolerated underlying rhythm or within 6 months of CIED implantation, including generator changes, unless there were compelling clinical reasons to proceed with MR and approved by an electrophysiologist. The 6-month period following CIED implantation was appreciated to be a conservative choice, and with institutional experience, more patients within this time period were approved for MR by the electrophysiologist. The exclusions for time from CIED implant and pacing dependence were removed from the protocol formally after July 2016. The protocol also excluded patients with abandoned, fractured, or epicardial leads; however, some patients with such leads were inadvertently scanned or permitted based on a review and deemed necessary, and reported in this study.
In the fall of 2016, an additional requirement of a chest x-ray was made for patients not previously followed in our pacemaker clinic or if the CIED hardware was uncertain to prevent inadvertent scans.
Immediately prior to MR scanning, in zone 2 or zone 3 of the MR suite, the CIED was evaluated to confirm appropriate CIED function including battery status, sensing, and pacing capture thresholds and then programmed for scanning. Patients who were not pacing dependent were programmed to a nonpacing mode, but if the underlying rhythm was below 50 beats/min, they could be programmed to an asynchronous pacing mode at the discretion of the electrophysiologist.
Pacing-dependent patients were programmed to asynchronous pacing. All advanced and adaptive features as well as tachycardia detection for ICDs were deactivated for scanning. Immediately following MR scanning, again in zone 2 or 3, the CIED was reevaluated and programming restored to initial parameters. All patients were monitored with the use of MR conditional equipment for electrocardiogram, heart rate, and pulse oximetry during the interval of time the patient was reprogrammed for scanning, and with nursing staff present who were trained in advanced cardiac life support. A follow-up CIED evaluation was performed 3-6 months after the MR scan, if the patient continued to be followed at our hospital.
MR imaging protocol
All MR scans were performed on a 1.5T system (Siemens Medi- 
Statistics
Differences in CIED variables were calculated from immediately prior to and immediately after MR scan, and from immediately prior to and at the 3-to 6-month follow-up CIED evaluation. CIED variable differences were calculated as the value post-MR scan (or at follow-up) minus the value pre-MR scan. CIED variables included sensing value (mV), pacing capture threshold (V), lead impedance (ohm), and battery voltage (V). Battery voltage was available for Medtronic devices. Data are presented as mean ± standard deviation (SD). Univariate regression analyses were performed to determine factors that were associated with CIED variable differences. Generalized linear mixed models with random effects were used to account for correlations within an individual subject with multiple MR scans. For CIED variable differences at follow-up, the regression analysis was restricted to patients who had only one MR scan to examine the long-term effects of a single scan and avoid potentially confounding effects of multiple scans prior to the follow-up assessment. Factors tested were region scanned (thoracic vs nonthoracic), as well as time in days from CIED implant to MR scan categorized in quartiles referenced to the first quartile and CIED device type (pacemaker vs ICD). Time in days from CIED implant to MR scan was also tested as a continuous variable. The significance of the constant value in the regression analysis was examined to determine whether the CIED variable difference was systematically nonzero (analogous to a paired t-test if each patient has only one scan). Since a cervical spine scan may overlap with one or two thoracic discs, we excluded cervical spine scans from the analysis of region scanned (thoracic vs nonthoracic). Statistical analyses were performed using Stata/IC, version 14.2 (StataCorp LP, College Station, TX, USA). A P-value of < 0.05 was considered statistically significant.
RESULTS
A total of 238 patients with an MR nonconditional CIED underwent 339 MR scans. The average patient age was 65 ± 15 years and 90 patients (38%) were female. About one-half of patients had a pacemaker, and 36 patients had a CRT-defibrillator (CRT-D) device. Characteristics of the cohort are given in Table 1 Table 2 . The constant terms in the regression analyses were not significant, indicating that CIED variable differences were not systematically different from zero (Table 2 ).
There was no significant association with thoracic versus nonthoracic region scanned, except for a trivial association for right ventricular (RV)
impedance of borderline significance (P = 0.04, Table 2 ). There was no significant association with CIED device type (pacemaker vs ICD).
There was no significant association with time from CIED implant to MR scan either treated as quartiles or as a continuous variable.
Device parameters immediately pre-MR scan and at follow-up are shown according to region scanned (thoracic or nonthoracic) in Figure 2 . Regression analysis was performed to assess CIED variable differences at follow-up for patients that underwent a single MR scan and with follow-up data available (83 patients). The constant terms in the regression analyses were not significant, indicating that CIED variable differences were not systematically different from zero, with the exception of a trivial reduction in atrial impedance (P = 0.03, Table 3 ). Differences in CIED variables were not significantly associated with MR region (thoracic vs nonthoracic), quartile of time from Note: *P-value for the constant in the regression analysis, signifying if the CIED variable difference is nonzero. CIED = cardiac implantable electronic device; MR = magnetic resonance; SD = standard deviation.
CIED implant to MR scan, or CIED device type (pacemaker vs ICD).
There were no significant associations of follow-up CIED variable differences to time from CIED implant to MR scan treated as a continuous variable with the exception for P wave amplitude difference, which was of borderline significance (P = 0.05).
DISCUSSION
In Note: *P-value for the constant in the regression analysis, signifying if the CIED variable difference is nonzero. CIED = cardiac implantable electronic device; MR = magnetic resonance; SD = standard deviation.
oversensing; and false detections of ventricular tachyarrhythmias 30 and power-on reset. 21, 31 Fractured, abandoned, and epicardial leads may have a higher risk for cardiac stimulation or heating, 32-34 though it is unclear if this is a clinically significant risk. 35 Nonetheless, several large cohort studies have suggested that MR scanning of nonconditional CIEDs can be performed successfully with no clinically significant adverse effects with an appropriate protocol. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The recently published MagnaSafe multicenter registry 14 reported 1,500 MR scans (1,000 in pacemakers and 500
in ICDs) with no adverse events. However, scans of thoracic regions were excluded in the MagnaSafe protocol. When the CIED is near the isocenter of the MR scan, the exposure to radiofrequency (RF) energy is greater and there may be a higher risk of lead heating, myocardial thermal injury, and CIED malfunction. 26 Additionally, the presence of the CIED can impact on thoracic image quality, though this may be avoided with certain scanning techniques. 36, 37 The largest single-center cohort that included thoracic scanning was reported by Johns Hopkins, which most recently was updated to include 257 patients with a thoracic scan, 21, 25 and another large cohort reported recently by the Oregon Health and Science University. 23 In these studies, there was no significant association of CIED variable differences to region scanned except for a minor change in RV impedance acutely and left ventricular impedance in follow-up in the Johns Hopkins cohort 25 and a minor change in RV impedance on follow-up in the Oregon Health and Science University cohort. 23 It must be recognized that actual RF energy exposure can vary according to the specific area of the body scanned, and specifically for different thoracic structures. It should also be acknowledged that the actual RF energy exposure can vary according to the number of sequences that are needed to adequately image an individual patient even for the same region scanned. It would be interesting to determine if outcomes are different for different thoracic structures, such as the thoracic spine, chest, and heart. However, to compare scans of different specific thoracic regions would require a cohort far larger than has been reported to date to achieve adequate statistical power. Thus, outcomes of thoracic scans reported here, as well as from the Johns
Hopkins and Oregon Health and Science cohorts, combine heart, thoracic spine, and the chest within a thoracic group.
This study expands upon the published literature on thoracic MR scanning in CIED patients. At our institution, thoracic MR scanning, including cardiac scans, are a significant portion of MR scans performed, constituting 36% in this prospective cohort, of which 60%
were to image the heart. We found that CIED performance was not defibrillate during defibrillation threshold testing despite normal function seen after a power-on reset. 38, 39 The evidence to support DFT testing after a power on reset is limited, and risks need to be assessed for the individual patient, though routine DFT testing after an MR scan appeared unnecessary in a cohort where this was assessed. 40 Regardless, despite the fact that device power-on reset is a rare event, this highlights the importance of following a protocol that includes continuous monitoring of the patient with a skilled CIED technician who is immediately available.
In addition to our primary focus on thoracic versus nonthoracic MR scanning, our study also evaluated associations with time from CIED implant to MR scan. No statistically significant associations were present. Our study though could not assess outcomes in patients with very recently implanted CIEDs, as only three patients had a device implanted within 6 weeks of MR scan. Our study is also reassuring that repeat MR scanning has no clinically meaningful effect on device parameters or patient outcomes, with 63 (26%) patients having undergone repeat scanning, in agreement with what was reported in the MagnaSafe registry, 14 and single-center cohorts. 19, 21, 23, 41 This study also included 13 patients (5.4% of the cohort) with either abandoned or epicardial leads. While their MR scans were completed with no adverse events, the risk of MR scanning in this patient population is considered to be higher and clinical data in the literature are limited to small single-center cohorts. For abandoned leads, one study reported no adverse events related to MRI in 19 patients with abandoned leads. 33 Similarly, no adverse events were seen with MRI in a cohort that included nine patients with epicardial leads, 42 and in nine congenital heart disease patients with epicardial leads. 43 Recently, a larger cohort of 80 patients with abandoned leads was reported with no adverse effects and no significant changes in troponin values. 44 The 2017 HRS consensus statement on MR imaging 2 makes no recommendations for MR scanning for this patient population. Further research is needed to identify the clinical situations that might justify the increased risk of an MR scan in patients with abandoned, fractured, or epicardial leads and an appropriate protocol.
Limitations
There were a limited number of patients who were pacing dependent, or with CIEDs implanted within 6 months of MR scanning, as these two conditions were excluded unless there were compelling clinical reasons to proceed with MR and approved by an electrophysiologist.
Long-term follow-up data were missing for about one-half of patients with one scan and it is unknown if the lack of follow-up data may have confounded the follow-up analysis. However, the additional information from patients with repeated scanning over time adds some further reassurance for continued stable CIED function over the long term. There were also a limited number of patients with noncardiac thoracic scans, and thus an analysis of outcomes comparing different types of thoracic scans would require a much larger cohort. Our study also has the limitations inherent to a cohort study, where there may be other confounding variables that are unknown. Additionally, a cohort study cannot adequately assess all of the possible combinations of hardware and patient characteristics, which require computer simulation, as done to achieve FDA approval of current MR-conditional CIED systems.
CONCLUSION
MR scanning of patients with nonconditional CIEDs was performed successfully without clinically significant changes in CIED function or adverse outcomes, using a specified institutional protocol, regardless of region scanned (thoracic vs nonthoracic).
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